Complete Genomics (GNOM) Pops on LFR Tech Testing Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. EXC
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. BAJAJHFL:I
10. CCHGY

July 11, 2012 1:04 PM EDT
Complete Genomics, Inc. (Nasdaq: GNOM) shares are spiking following encouraging data for its Long Fragment Read (LFR) technology for whole genome sequencing dramatically improves accuracy, enables fully-phased genomes, and significantly reduces the amount of DNA required for testing.

Shares are up about 10 percent.

For more color, click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Momentum Movers